Jennifer Schneider
CIK: 0001783060
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRTX
VERTEX PHARMACEUTICALS INC / MA
Director
Discretionary Trading P&L
Holdings
About Schneider Jennifer
Schneider Jennifer (SEC CIK 0001783060) files insider reports with the SEC as Director of VERTEX PHARMACEUTICALS INC / MA (VRTX).
Signal8 holds 2 ownership filings by Schneider Jennifer, all Form 4s, filed between May 5, 2025 and May 5, 2026. Those filings report 3 transactions, from May 1, 2025 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schneider Jennifer's filings is in BOSTON, MA.
Recent filings by Schneider Jennifer
Other insiders filing for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Brennan Daniel J., Director
- SACHS BRUCE I, Director
- Garber Alan M, Director
- van Grunsven Jasper, EVP, CP and NPPO
- Ambrose Kristen, SVP & Chief Accounting Officer
- Tatsis Ourania, EVP, Chief Reg. & Quality Off.